Home > IR Information > Consolidated Business Performance
Consolidated Business Performance
Consolidated-to-Non-consolidated Ratios of Operating Income and Ordinary Income
| 2006.3 | 2007.3 | 2008.3 | 2009.3 | 2010.3 | |
|---|---|---|---|---|---|
Consolidated-to-non-consolidated sales ratio |
1.58 | 1.60 | 1.60 | 1.65 | 1.71 |
Consolidated-to-non-consolidated operating income ratio |
1.29 | 1.34 | 1.42 | 3.44 | 4.60 |
Consolidated-to-non-consolidated ordinary income ratio |
1.20 | 1.17 | 1.25 | 1.91 | 2.60 |
Research and Development Expenses, (Sales-to-Research and Development Expenses Ratio)
| 2006.3 | 2007.3 | 2008.3 | 2009.3 | 2010.3 | |
|---|---|---|---|---|---|
Research and development expenses
(unit: hundred million yen) |
169 | 169 | 166 | 172 | 163 |
(Sales-to-research and development expenses ratio)
(unit: %) |
(3.6) | (3.6) | (3.3) | (3.8) | (4.0) |
Segment Information
Sales by Segment Sectors
Chemicals
Functional Plastics
Expandable Plastics
Foodstuffs Products
Life Science Products
Electronic Products
Synthetic Fibers and Others
Sales-to-Overseas Sales Ratio
International sales
Overseas Sales
Asia
North America
Europe
Others